Active Ingredient History
Artemisinin and its semisynthetic derivatives are a group of drugs used in the treatment of malaria due to Plasmodium falciparum. It was discovered in 1972 by Tu Youyou, who shared the 2015 Nobel Prize in Physiology or Medicine for her discovery. Artemisinin-based combination therapies (ACTs) are now standard treatment worldwide for P. falciparum malaria as well as malaria due to other species of Plasmodium. Artemisinin is extracted from the plant Artemisia annua a herb employed in Chinese traditional medicine. A precursor compound can be produced using a genetically engineered yeast, which is much more efficient than using the plant. Wikipedia
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Carcinoma (Phase 2)
Coronavirus (Phase 2)
Coronavirus Infections (Phase 3)
COVID-19 (Phase 4)
Drug Combinations (Phase 1)
Genital Neoplasms, Female (Phase 2)
Healthy Volunteers (Phase 1)
Lupus Erythematosus, Systemic (Phase 2)
Malaria (Phase 4)
Malaria, Falciparum (Phase 4)
Malaria, Vivax (Phase 4)
Neoplasms (Phase 2)
Papillomavirus Infections (Phase 2)
Parasitic Diseases (Phase 4)
Pharmacokinetics (Phase 1)
Plasmodium falciparum (Phase 4)
Schizophrenia (Phase 3)
Severe Acute Respiratory Syndrome (Phase 3)
Vulvar Diseases (Phase 2)
Vulvar Neoplasms (Phase 2)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue